PRESS RELEASE published on 07/30/2025 at 14:29, 7 months 18 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025 Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
BRIEF published on 07/30/2025 at 13:47, 7 months 18 days ago Medincell's UZEDY® and Olanzapine LAI Forecast Promising Financial Outcomes Schizophrenia Treatment Teva Pharmaceuticals Medincell Revenue Forecast UZEDY® Performance Olanzapine LAI Development
PRESS RELEASE published on 07/30/2025 at 13:42, 7 months 18 days ago Inside Information / Other news releases Medincell's partner Teva increases 2025 revenue outlook for UZEDY® to $190–$200M, plans olanzapine LAI submission. Company's innovative treatments aim to improve medicine accessibility Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 07/30/2025 at 11:43, 7 months 18 days ago Medincell Releases 2024-25 Universal Registration Document Shareholders Governance Financial Report CSR Medincell
PRESS RELEASE published on 07/30/2025 at 11:38, 7 months 18 days ago Annual financial and audit reports / Terms of availability of the annual financial report Medincell announces availability of its 2024-25 Universal Registration Document, including financial and CSR reports. Innovative treatments developed aim to improve effectiveness of medicines Financial Reports Universal Registration Document CSR Innovative Treatments Medincell
BRIEF published on 05/07/2025 at 15:17, 10 months 10 days ago Medincell's Growth in Antipsychotic Treatments FDA Filing Medincell Olanzapine LAI UZEDY Antipsychotics
PRESS RELEASE published on 05/07/2025 at 15:12, 10 months 10 days ago Inside Information / Other news releases Medincell's UZEDY® sees strong sales growth in Q1 2025 with plans for Olanzapine LAI FDA submission in H2 2025. Teva's partner shares updates on key products Medincell FDA Submission Teva Pharmaceuticals Olanzapine LAI UZEDY
BRIEF published on 04/15/2025 at 19:53, 11 months 2 days ago Medincell increases its liquidity contract to support securities trading Liquidity Contract Rothschild Martin Maurel Actions EU Regulations Medincell
PRESS RELEASE published on 04/15/2025 at 19:48, 11 months 2 days ago Inside Information / Other news releases Medincell increases liquidity contract resources by 600,000 euros with Rothschild Martin Maurel to support higher trading volumes Liquidity Contract Rothschild Martin Maurel Amendment Medincell Trading Volumes
BRIEF published on 03/10/2025 at 11:54, 1 year ago Adage Capital exceeds 5% in MEDINCELL Euronext Paris Actions Threshold Crossing Medincell Adage Capital
Published on 03/17/2026 at 13:30, 6 hours 40 minutes ago Hillcrest Energy Technologies Confirms ZVS PCS1000 Prototype on Track for June 2026
Published on 03/17/2026 at 13:30, 6 hours 40 minutes ago Namibia Critical Metals Welcomes Toyota Tsusho as Strategic Partner in the Lofdal Heavy Rare Earths Project
Published on 03/17/2026 at 13:00, 7 hours 10 minutes ago Avant Brands Announces Strategic Realignment of European Operations and Reclaims BLK MKT Brand Rights in Germany and Switzerland
Published on 03/17/2026 at 13:00, 7 hours 10 minutes ago High-Resolution Airborne Survey Completed at Music Valley HREE Project
Published on 03/17/2026 at 12:30, 7 hours 40 minutes ago Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho
Published on 03/17/2026 at 17:58, 2 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/17/2026 at 15:30, 4 hours 40 minutes ago Original-Research: Desert Gold Ventures Inc. (von GBC AG): Buy
Published on 03/17/2026 at 15:19, 4 hours 51 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 03/17/2026 at 07:00, 13 hours 10 minutes ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 2 hours ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 2 hours ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 2 hours ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
